Literature DB >> 24639184

eComment. Application of prostaglandin E1 and pentoxyphylline in clinical mesenteric ischaemia.

Nicolas J Mouawad1, Mounir J Haurani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24639184      PMCID： PMC3957303          DOI： 10.1093/icvts/ivu017

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  4 in total

1.  Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia-reperfusion injury.

Authors:  Enrique María San Norberto García; James Henry Taylor; Noelia Cenizo; Carlos Vaquero
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-01-14

2.  Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1).

Authors:  Akira Mitsuyoshi; Kazutaka Obama; Nobuhiko Shinkura; Takashi Ito; Masazumi Zaima
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

3.  Pentoxifylline protects the small intestine after severe ischemia and reperfusion.

Authors:  José Miguel Lloris Carsi; Dolores Cejalvo Lapeña; Alexander Horacio Toledo; Cristobal Zaragoza Fernandez; Luis Horacio Toledo Pereyra
Journal:  Exp Clin Transplant       Date:  2013-06       Impact factor: 0.945

4.  Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.

Authors:  H Bitterman; N Aoki; A M Lefer
Journal:  Proc Soc Exp Biol Med       Date:  1988-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.